Form 4: STERIS Executive Reports Share Transactions

Cary L. Majors, SVP and President of Healthcare at STERIS plc, reported a series of transactions involving ordinary shares, including the vesting of restricted shares and the withholding of shares for tax purposes.

Summary

• Cary L. Majors, an officer of STERIS plc, has reported changes in beneficial ownership of the company's ordinary shares.
• On June 1, 2026, 768 ordinary shares were withheld from a total of 2,697 restricted shares that vested on that date. These withheld shares were used to cover applicable tax liabilities.
• The vested shares were valued at the NYSE closing market price on June 1, 2026.
• Following these transactions, Mr. Majors beneficially owns 12,659 ordinary shares directly.
• Additionally, 7,441 ordinary shares remain restricted, with restrictions lapsing on various dates through June 5, 2028.
• As of May 29, 2026, 67 ordinary share equivalents were held in the STERIS Corporation 401(k) Plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it primarily reports routine share transactions for tax purposes and vesting, rather than indicating significant new investment or divestment by management.

Positives

• Vesting of restricted shares indicates continued employee incentive and potential for increased ownership.
• The company is managing tax withholding efficiently by using vested shares.
• A significant portion of restricted shares are scheduled to vest in the near future, suggesting ongoing commitment from management.

Negatives

• Withholding of shares for tax purposes reduces the net number of shares received by the executive.
• A substantial number of shares remain restricted, indicating that full ownership is still contingent on future vesting periods.

Risks

• The value of withheld shares is subject to market price fluctuations on the vesting date.
• Future vesting of restricted shares is contingent on continued employment and potentially other performance metrics not detailed in this filing.

Future Outlook

The filing details the vesting schedule for restricted shares, indicating future potential increases in beneficial ownership for the reporting person as restrictions lapse on specific dates through June 2028.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for executives and directors regarding their company's stock transactions. This filing provides insight into executive compensation and potential insider sentiment, but does not offer strategic or financial performance updates.

Stakeholder Impact

• Shareholders: The transaction details provide transparency into executive compensation and potential insider holdings, which can inform investor sentiment.
• Employees: The vesting of restricted shares and the operation of the 401(k) plan highlight employee benefit programs.
• Management: The filing reflects standard executive compensation practices and tax management.

Next Steps

• Lapsing of restrictions on 2,140 restricted shares on June 2, 2026.
• Lapsing of restrictions on 2,379 restricted shares on June 4, 2027.
• Lapsing of restrictions on 2,922 restricted shares on June 5, 2028.

Key Dates

Keywords

STERIS plc, STE, Form 4, Insider Trading, Share Vesting, Restricted Stock, Tax Withholding, Beneficial Ownership, Executive Compensation, Securities Exchange Act